CIC
RGNX icon

Cornercap Investment Counsel’s Regenxbio RGNX Stock Holding History

Cornercap Investment Counsel’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,168
Closed -$142K – 626
2024
Q2 		$142K Sell
12,168
-88
-0.7% -$1.37K 0.02% 561
2024
Q1 		$258K Buy
12,256
+354
+3% +$6.3K 0.04% 535
2023
Q4 		$214K Sell
11,902
-19
-0.2% -$335 0.04% 525
2023
Q3 		$196K Sell
11,921
-153
-1% -$2.77K 0.04% 493
2023
Q2 		$241K Buy
+12,074
New +$233K 0.04% 486

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Cornercap Investment Counsel's RGNX Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of Regenxbio (RGNX) in Q3 2024, closing a stake of 12,168 shares — an estimated $142K sold.

Cornercap Investment Counsel first reported a position in RGNX in Q2 2023 and held it in 5 quarters. The position peaked at $258K in Q1 2024. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining Regenxbio position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 12,168 Regenxbio shares in Q3 2024, an estimated $142K.
  • Cornercap Investment Counsel first reported a position in Regenxbio in Q2 2023 and held it in 5 quarters.
  • Cornercap Investment Counsel's Regenxbio position peaked at $258K in Q1 2024.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.